Sol. Inj. in Stilou Injector (pen) Preumplut

101 medicamente sub formă de sol. inj. in stilou injector (pen) preumplut autorizate în România.

Denumire comercială Substanță activă (DCI) Concentrație Producător Cod ATC
Abasaglar Insulinum Glargine 100UI/ml Lilly France S.a.s - Franta A10AE04
AJOVY 225 mg Fremanezumabum 150mg/ml Teva Pharmaceuticals Europe B.v. - Olanda N02CD03
AVONEX 30µg/0,5ml PEN Interferonum Beta 1a 30µg/0,5ml Biogen (denmark) Manufacturing Aps - Danemarca L03AB07
BEMFOLA 150 UI/0,25 ml Follitropinum Alfa 150UI/0,25ml Finox Biotech Ag - Liechtenstein G03GA05
BEMFOLA 225 UI/0,375 ml Follitropinum Alfa 225UI/0,375ml Finox Biotech Ag - Liechtenstein G03GA05
BEMFOLA 300 UI/0,50 ml Follitropinum Alfa 300UI/0,5ml Finox Biotech Ag - Liechtenstein G03GA05
BEMFOLA 75 UI/0,125 ml Follitropinum Alfa 75UI/0,125ml Finox Biotech Ag - Liechtenstein G03GA05
DUPIXENT 200 mg Dupilumabum 175mg/ml Sanofi-Aventis Deutschland Gmbh - Franta D11AH05
DUPIXENT 300 mg Dupilumabum 150mg/ml Sanofi Winthrop Industrie - Franta D11AH05
EMGALITY 120 mg Galcanezumabum 120mg/ml Eli Lilly Italia Spa - Italia N02CD02
ENTYVIO 108 mg Vedolizumabum 108mg Delpharm Novara S.r.l. - Italia L04AG05
FASENRA 30 mg Benralizumabum 30mg Astrazeneca Ab - Suedia R03DX10
HUMALOG 100 unitati/ml JUNIOR KWIKPEN Insulinum Lispro 100unitati/ml Lilly France S.a.s. - Franta A10AB04
HUMALOG 200 UNITATI/ml Insulinum Lispro 200unitati/ml Lilly France S.a.s. - Franta A10AB04
ILARIS 150 mg/ml Canakinumabum 150mg/ml Novartis Pharma Gmbh - Germania L04AC08
LYUMJEV 100 unitati/ml JUNIOR KWIKPEN Insulinum Lispro 100U/ml Lilly France S.a.s. - Franta A10AB04
LYUMJEV 100U/ml Insulinum Lispro 100U/ml Lilly France S.a.s. - Franta A10AB04
LYUMJEV 200U/ml Insulinum Lispro 200 U/ml Lilly France S.a.s - Franta A10AB04
MOUNJARO 10 mg Tirzepatidum 10mg Eli Lilly Italia S.p.a. - Italia A10BX16
MOUNJARO 12,5 mg Tirzepatidum 12,5mg Eli Lilly Italia S.p.a. - Italia A10BX16
MOUNJARO 15 mg Tirzepatidum 15mg Eli Lilly Italia S.p.a. - Italia A10BX16
MOUNJARO 2,5 mg Tirzepatidum 2,5mg Eli Lilly Italia S.p.a. - Italia A10BX16
MOUNJARO 5 mg Tirzepatidum 5mg Eli Lilly Italia S.p.a. - Italia A10BX16
MOUNJARO 7,5 mg Tirzepatidum 7,5mg Eli Lilly Italia S.p.a. - Italia A10BX16
NGENLA 24 mg Somatrogonum 24 mg/1,2 ml Pfizer Manufacturing Belgium Nv - Belgia H01AC08
NGENLA 60 mg Somatrogonum 60 mg/1,2 ml Pfizer Manufacturing Belgium Nv - Belgia H01AC08
NORDIMET 10 mg Methotrexatum 10mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 12,5 mg Methotrexatum 12,5mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 15 mg Methotrexatum 15mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 17,5 mg Methotrexatum 17,5mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 20 mg Methotrexatum 20mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 22,5 mg Methotrexatum 22,5mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 25 mg Methotrexatum 25mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
NORDIMET 7,5 mg Methotrexatum 7,5mg Cenexi - Laboratoires Thissen S.a. - Belgia L04AX03
OVITRELLE 250 mcg Gonadotrophinum Chorionicum Alfa 250mcg Merck Serono Spa - Italia G03GA08
OZEMPIC 0,25 mg Semaglutidum 1,34mg/ml Novo Nordisk a/S - Danemarca A10BJ06
OZEMPIC 0,5 mg Semaglutidum 1,34mg/ml Novo Nordisk a/S - Danemarca A10BJ06
OZEMPIC 1 mg Semaglutidum 1,34mg/ml Novo Nordisk a/S - Danemarca A10BJ06
OZEMPIC 2 mg Semaglutidum 2,68mg/ml Novo Nordisk a/S - Danemarca A10BJ06
PERGOVERIS (300 UI+150 UI)/0,48 ml Combinatii (follitropinum Alfa+lutropinum Alfa) (300UI+150UI)/0,48ml Merck Serono S.p.a. - Italia G03GA30
PERGOVERIS (450 UI+225 UI)/0,72 ml Combinatii (follitropinum Alfa+lutropinum Alfa) (450UI+225UI)/0,72ml Merck Serono S.p.a. - Italia G03GA30
PERGOVERIS (900 UI+450 UI)/1,44 ml Combinatii (follitropinum Alfa+lutropinum Alfa) (900UI+450UI)/1,44ml Merck Serono S.p.a. - Italia G03GA30
PRALUENT 150 mg Alirocumabum 150mg Sanofi-Aventis Deutschland Gmbh - Germania C10AX14
PRALUENT 300 mg Alirocumabum 300mg Sanofi-Aventis Deutschland Gmbh - Germania C10AX14
PRALUENT 75 mg Alirocumabum 75mg Sanofi-Aventis Deutschland Gmbh - Germania C10AX14
SOGROYA 10 mg/1,5 ml Somapacitanum 10mg/1,5ml Novo Nordisk a/S - Danemarca H01AC07
SOGROYA 5 mg/1,5 ml Somapacitanum 5mg/1,5ml Novo Nordisk a/S - Danemarca H01AC07
SULIQUA 100 unitati/ml+33 micrograme/ml Combinatii (insulinum Glargine+lixisenatidum) 100unitati/ml+33micrograme/ml Sanofi-Aventis Deutschland Gmbh - Germania A10AE54
SULIQUA 100 unitati/ml+50 micrograme/ml Combinatii (insulinum Glargine+lixisenatidum) 100unitati/ml+50micrograme/ml Sanofi-Aventis Deutschland Gmbh - Germania A10AE54
TEZSPIRE 210 mg Tezepelumabum 110mg/ml Astrazeneca Ab - Suedia R03DX11
TOUJEO 300 Unitati/ml Insulinum Glargine 300unitati/ml Sanofi-Aventis Deutschland Gmbh - Germania A10AE04
TOUJEO 300 Unitati/ml DOUBLESTAR Insulinum Glargine 300unitati/ml Sanofi-Aventis Deutschland Gmbh - Germania A10AE04
TREMFYA 100 mg PushPen Guselkumabum 100mg Janssen Biologics B.v. - Olanda L04AC16
TREMFYA 200 mg Guselkumabum 200mg Janssen Biologics B.v. - Olanda L04AC16
TREMFYA 45 mg/0,45 ml Guselkumabum 45mg/0,45ml Janssen Biologics B.v. - Olanda L04AC16
XULTOPHY 100 unitati/ml + 3,6 mg/ml Combinatii (insulinum Degludec+liraglutidum) 100U/ml+3,6mg/ml Novo Nordisk a/S - Danemarca A10AE56

Forme similare

Sol. Inj. (780) Sol. Perf. (752) Sol. Inj. in Seringa Preumpluta (579) Conc. Pt. Sol. Perf. (462) Sol. Inj./Perf. (288) Pulb. Pt. Sol. Inj./Perf. (255)